Back to top
more

Cigna Group (CI)

(Delayed Data from NYSE)

$279.27 USD

279.27
2,445,750

-5.82 (-2.04%)

Updated Jun 18, 2026 04:00 PM ET

After-Market: $279.37 +0.10 (0.04%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.00%
2Buy18.14%
3Hold10.18%
4Sell5.72%
5Strong Sell3.11%
S&P50011.49%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value D Growth F Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 17% (41 out of 247)

Industry: Medical - HMOs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Kaibalya Pravo Dey headshot

UnitedHealth vs. Cigna: Which Insurer to Buy Amid Sector Turmoil?

by Kaibalya Pravo Dey

CI's commercial focus and clearer outlook set it apart as UNH faces guidance pulls, CEO change and rising medical costs.

Moumi Mondal headshot

Is CVS Moving Closer to Reaching Its Long-Term Low 3X Leverage Goal?

by Moumi Mondal

CVS Health inches closer to its long-term leverage target, helped by Aetna margin recovery and disciplined cash use.

Zacks Equity Research

Humana Expands Medicaid Footprint With Virginia's Cardinal Care Win

by Zacks Equity Research

Cardinal Care taps HUM to offer its Healthy Horizons Medicaid plan, unlocking new growth in Virginia's healthcare market.

Zacks Equity Research

Cigna Expands Coverage With RhinAer & Enhances Rhinitis Treatment

by Zacks Equity Research

CI to cover RhinAer for chronic rhinitis starting Sept. 15, expanding access to a minimally invasive, office-based treatment.

Zacks Equity Research

Zacks Industry Outlook Highlights Cigna, Humana, Centene and Molina Healthcare

by Zacks Equity Research

CNC, MOH, CI, and HUM are set to benefit from Medicare demand, steady premiums, and tech-driven growth in the HMO space.

Debasmita Chatterjee headshot

4 HMO Stocks Set to Thrive From Steady Premium Flows, M&A Strategy

by Debasmita Chatterjee

Rising premiums, ongoing technological innovation and the growing demand for Medicare plans are anticipated to propel the performance of the Zacks Medical-HMO industry players. CI, HUM, CNC and MOH are poised to benefit from favorable industry prospects.

Mark Vickery headshot

Top Research Reports for Apple, AMD & Applied Materials

by Mark Vickery

AAPL, AMD and AMAT lead today's top research picks, with insights on growth drivers, challenges, and shifting tech demand.

Moumi Mondal headshot

Exploring CVS' Health Services Segment: A Key Growth Engine for 2025?

by Moumi Mondal

CVS' Health Services segment posts $43B in revenues as specialty pharmacy and Caremark deals drive 2025 growth prospects.

Zacks Equity Research

Should You Invest in the iShares U.S. Healthcare Providers ETF (IHF)?

by Zacks Equity Research

Sector ETF report for IHF

Zacks Equity Research

Here's Why You Should Hold Cigna Stock in Your Portfolio for Now

by Zacks Equity Research

CI gains 14.7% YTD as Evernorth and Cigna Healthcare drive growth, but rising expenses and debt pose challenges.